Abstract:Introduction: Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations. Methods: First, we used gene co-expression network analysis of published data to test the hypothesis that Grn has a critical role in regulating the activation status of immune cell populations in both central and peripheral compartments. To investigate the extent to which PGRN-deficiency resulted in immune dysregulation, we performed deep immunophenotyping by flow cytometry of 19-24-month old male and female Grn-deficient mice (PGRN KO) and littermate Grn-sufficient controls (WT). Results: Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8+ T cells compared to WT mice. Furthermore, we observed an increase in CD44 on CD8+ T cells in the peripheral blood. Female PGRN KO mice also had fewer microglia compared to WT mice, and we also observed reduced expression of MHC-II on brain monocytes. Additionally, we found an increase in Ly-6Chigh monocyte frequency and decreased CD44 expression on CD8+ and CD4+ T cells in PGRN KO female blood. Given that Gpnmb, which encodes for the lysosomal protein Glycoprotein non-metastatic melanoma protein B, has been reported to be upregulated in PGRN KO mice, we investigated changes in GPNMB protein expression associated with PGRN deficits and found that GPNMB is modulated in myeloid cells in a sex-specific manner. Discussion: Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.

Progranulin Expression in Neural Stem Cells and Their Differentiated Cell Lineages: an Immunocytochemical Study

Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway.

Expression of PPARγ in the Neural Stem Cells

The distribution of PGRN positive neurons in cerebral cortex of newborn rats

Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis

Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons

Effects of Granulocyte Colony-Stimulating Factor on the Proliferation and Cell-Fate Specification of Neural Stem Cells

Progranulin regulates neurogenesis in the developing vertebrate retina

Gpr56 is Highly Expressed in Neural Stem Cells but Downregulated During Differentiation

Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system

Effect of Neural Stem Cells Transplantation on Protein Expressions of Doublecortin and Nestin in Hippocampal Regions in App/ps1 Mice

The Mental Retardation-Associated Protein Srgap3 Regulates Survival, Proliferation, and Differentiation of Rat Embryonic Neural Stem/Progenitor Cells

Neuroprotective Effects of Progranulin in Ischemic Mice.

Progranulin promotes osteogenic differentiation of periodontal membrane stem cells in both inflammatory and non-inflammatory conditions.

Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation.

PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway.

Progranulin improves neural development via the PI3K/Akt/GSK-3β pathway in the cerebellum of a VPA-induced rat model of ASD

Progranulin as a therapeutic target in neurodegenerative diseases

Selective neuronal expression of progranulin is sufficient to provide neuroprotective and anti-inflammatory effects after traumatic brain injury